HONOLULU, Feb. 27, 2017 -- Attorney Margaret Dore, president of Choice is an Illusion, which is fighting assisted suicide and euthanasia legalization efforts throughout the United States, made the following statement in connection with an assisted suicide/euthanasia bill set for hearing tomorrow in the Hawaii State Senate Committee on Judiciary and Labor. The bill is SB 1129 S.D. 1.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/58967841-09da-4273-934a-f638de752bac
“The bill seeks to pass a proposed act legalizing assisted suicide and allowing euthanasia,” said Dore. “If enacted, the act will apply to people with years or decades to live. The act is a recipe for elder abuse, especially for people with money, meaning the middle class and above in the inheritance situation.”
Dore said, "The proposed act allows the patient's heir, who will financially benefit from the patient's death, to actively participate in requesting the lethal dose. After that, no doctor, not even a witness, is required to be present at the death. Even if the patient struggled, who would know?"
"But, it gets worse," said Dore, "the death certificate is required to list a terminal disease as the cause of death, which prevents prosecution." Dore explained, "The official cause of death is a terminal disease (not murder) as a matter of law. For inheritance perpetrators, the death certificate is a 'stay out of jail free card.'”
Dore stated, “If enacted, the proposed act will legalize assisted suicide and euthanasia for people who are 'terminal,' which is defined as a doctor's prediction of less than six months to live. In real life, such persons may have years or decades to live."
"Doctors can be wrong about life expectancy, sometimes way wrong," said Dore. "This is due to mistakes and the fact that predicting life expectancy is not an exact science. A few years ago, I was met at the airport by a man who at age 18 or 19 had been diagnosed with ALS (Lou Gehrig's disease) and given 3 to 5 years to live, at which time he would die by paralysis. His diagnosis had been confirmed by the Mayo Clinic. When he met me at the airport, he was 74 years old. The disease progression had stopped on its own."
Dore stated, “The proposed act is based on a similar law in Oregon. In Oregon, a young adult with insulin dependent diabetes is ‘terminal’ because the six months to live is determined without treatment. A typical insulin dependent adult will live less than a month without insulin. Such persons are therefore ‘terminal’ for the purpose of assisted suicide.”
Dore added, “By contrast, with insulin, such persons may have decades to years or decades to live.”
Dore concluded, “The proposed act will create the perfect crime and encourage people with years or decades to live to throw away their lives. The act must be rejected.”
For more information, see “Dore Memo Opposing SB 1129 SD1,” which can be viewed at these links: memo and appendix.
Contact: Margaret Dore, Esq., MBA President [email protected] (206) 697-1217


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Anta Sports Expands Global Footprint With Strategic Puma Stake
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



